Study sheds light on how coronavirus may hijack human cells


PTI, Feb 13, 2021, 1:03 PM IST

Credit: iStock Photo

Berlin: Scientists, including one of Indian-origin, have identified parts of human proteins which the novel coronavirus could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating COVID-19.

The researchers, including Manjeet Kumar from the European Molecular Biology Laboratory (EMBL) in Germany, analysed the chain of amino acid molecules that makes up the human proteins involved in the coronavirus infection, such as a class of proteins called integrins.

Previous research had found that the SARS-CoV-2 virus that causes COVID-19, enters cells through a process called endocytosis upon binding to the cell surface receptor ACE2 and potentially other proteins like integrins.

In the current study, published in the journal Science Signalling, the scientists focussed particularly on short strings of amino acids called short linear motifs (SLiMs), which are involved in transmitting information between the inside and outside of cells.

They saw that several integrins contain SLiMs that are likely involved in the cellular processes of uptake and disposal of substances called endocytosis and autophagy.

“If SARS-CoV-2 targets proteins involved in endocytosis and autophagy, it means these processes might be hijacked by the virus during infection,” said Balint Meszaros, a co-author of the study from EMBL.

The researchers believe the findings may lead to new therapeutic approaches for COVID-19.

“SLiMs could ‘switch’ to turn viral entry signals on or off. This means that if we can find a way to reverse these switches using drugs, this might stop coronavirus from entering cells,” explained study senior author Lucia Chemes.

“Together, these findings have identified a potential link between autophagy and integrin signaling and could lead to new ways to prevent viral infection,” the scientists wrote in the study.

Based on the results, the researchers gathered a list of existing drugs that interfere with endocytosis and autophagy.

“If clinical trials prove some of these drugs to work against COVID-19, this could be a game changer,” Kumar added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Essar Group co-founder Shashi Ruia dies at 80

Battle royal at Udaipur palace after BJP’s Vishvaraj Singh denied entry over family feud

RBI Governor Shaktikanta Das hospitalised

Had to sell land to realise dream: Vaibhav’s father

Eligible families won’t be inconvenienced with BPL card revision: Karnataka minister Muniyappa

Boy chokes to death after eating more than three pooris together

PWD, Google Maps officials booked in Bareilly bridge death case

Related Articles More

Rapid digital expansion to create over 1 lakh new jobs in fiber tech in India in next 5 years

National Consumer Helpline to roll out AI-based features, partners with 1,000 firms

BTS2024: If India can make rocket sensors, it can also make car sensors, says ISRO chief Somanath

World COPD Day: Know your lung function

SpaceX successfully launches ISRO’s 4,700 kg communication satellite from US

MUST WATCH

Coconut Flower

Prakash Belawadi

Naxal Leader Vikram Gowda

Christmas Cake Fruit Mixing

DK Shivakumar


Latest Additions

President Murmu pays homage to bravehearts who lost lives in Mumbai terror attack

Essar Group co-founder Shashi Ruia dies at 80

PM Modi greets people on Samvidhan Divas

Sensex, Nifty climb in early trade amid fresh foreign fund inflows

Amur falcon bird radio tagged in Manipur reaches Kenya

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.